Retinal vein occlusion (RVO) is an interruption of the normal venous drainage from the retinal tissue. Either the central vein or one of its branches can become occluded. Uncommonly, the occlusion can occur in a vein that drains half of the retina. This is referred to as a hemiretinal vein occlusion (HRVO).
DelveInsight's "Retinal Vein Occlusion (RVO) Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the Retinal Vein Occlusion (RVO), historical and forecasted epidemiology as well as the Retinal Vein Occlusion (RVO) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Retinal Vein Occlusion (RVO) Market Key Facts
-
According to the study conducted by Kolar et al., titled “Risk Factors for Central and Branch Retinal Vein Occlusion: A Meta-Analysis of Published Clinical Data,” RVO is more prevalent in men than women and is more frequent in older age (over 65 years).
-
Among the RVO patients, males show a higher proportion of prevalence of RVO as compared to females in the 7MM
-
RVO is more prominent in patients of age above 65 years in the 7MM.
-
The United States has the highest percentage of diagnosed and treated patients of Retinal Vein Occlusion in 7MM.
Retinal Vein Occlusion (RVO) Market Size, Share, and Growth Analysis
The market size of Retinal Vein Occlusion (RVO) shall grow during the forecast period owing to the launch of upcoming therapies.
The Retinal Vein Occlusion (RVO) market outlook section of the report helps to build the detailed comprehension of the historic, current, and forecasted Retinal Vein Occlusion (RVO) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Retinal Vein Occlusion (RVO) market trends and shares analysis of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Some of the key players in the Retinal Vein Occlusion market include:
Panoptes Pharma
Outlook Therapeutics
Graybug Vision
Merck
Genentech
Regeneron
Allergan
Kodiak Sciences
And many others
For more detailed information on Retinal Vein Occlusion (RVO) market Size, Share, and Growth analysis, visit: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market